Pei-Yi Chen Selected Research

Pei-Yi Chen Research Topics

Disease

9	Neoplasms (Cancer) 11/2023 - 01/2013
6	Leukemia 11/2023 - 01/2013
6	Infections 08/2022 - 01/2021
4	COVID-19 01/2022 - 01/2021
3	Hyperlipidemias (Hyperlipidemia) 10/2022 - 10/2019
3	Dyslipidemias (Dyslipidemia) 10/2022 - 07/2021
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2022 - 09/2021
2	Obesity 10/2022 - 09/2021
2	Hypercholesterolemia 10/2019 - 11/2014
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2018 - 12/2016
2	Pituitary Neoplasms (Pituitary Adenoma) 04/2018 - 01/2013
1	Prostatic Neoplasms (Prostate Cancer) 01/2024
1	Gestational Diabetes (Gestational Diabetes Mellitus) 10/2022
1	Virus Diseases (Viral Diseases) 09/2022
1	Disease Progression 02/2022
1	Pulmonary Edema 12/2021
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2019
1	Atherosclerosis 10/2019
1	Carcinoma (Carcinomatosis) 05/2018
1	Myeloid Leukemia (Leukemia, Myelocytic) 04/2018
1	Bacterial Infections (Bacterial Infection) 01/2018
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 10/2017
1	Inflammation (Inflammations) 01/2016
1	Alzheimer Disease (Alzheimer's Disease) 01/2015
1	Hypoxia (Hypoxemia) 01/2015
1	Hematologic Neoplasms (Hematological Malignancy) 01/2013
1	Neuroinflammatory Diseases 01/2012
1	Pheochromocytoma 01/2011
1	Tardive Dyskinesia 11/2010
1	Major Depressive Disorder (Major Depressive Disorders) 11/2010
1	Dystonia (Limb Dystonia) 11/2010
1	Dyskinesias (Dyskinesia) 11/2010
1	Trismus (Lockjaw) 11/2010
1	Hydatidiform Mole (Molar Pregnancy) 12/2008

Drug/Important Bio-Agent (IBA)

6	VaccinesIBA 02/2022 - 01/2021
4	PhytochemicalsIBA 07/2022 - 01/2016
3	nobiletinIBA 10/2022 - 12/2018
3	FlavonoidsIBA 10/2022 - 01/2015
3	Phosphotransferases (Kinase)IBA 01/2020 - 12/2016
2	Messenger RNA (mRNA)IBA 08/2022 - 12/2018
2	CytokinesIBA 02/2022 - 12/2021
2	Immune Sera (Antisera)IBA 01/2022 - 01/2022
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2018
2	Lipoproteins (Lipoprotein)IBA 09/2021 - 07/2021
2	QuinazolinesIBA 01/2020 - 12/2016
2	Small Interfering RNA (siRNA)IBA 12/2018 - 04/2018
2	AntioxidantsIBA 04/2018 - 01/2015
1	Hormones (Hormone)IBA 01/2024
1	pinostrobinIBA 11/2023
1	Glucagon-Like Peptide 1 (GLP 1)IBA 10/2022
1	florfenicolIBA 09/2022
1	BNT162 VaccineIBA 01/2022
1	2019-nCoV Vaccine mRNA-1273IBA 01/2022
1	Neutralizing AntibodiesIBA 01/2022
1	Lipid NanoparticlesIBA 12/2021
1	tangeretinIBA 09/2021
1	LipidsIBA 09/2021
1	Monoclonal AntibodiesIBA 07/2021
1	oxidized low density lipoproteinIBA 07/2021
1	Antisense OligonucleotidesIBA 07/2021
1	LDL CholesterolIBA 07/2021
1	Triglycerides (Triacylglycerol)IBA 07/2021
1	Angiopoietin-Like Protein 3IBA 07/2021
1	ErbB Receptors (EGF Receptor)IBA 11/2019
1	xanthohumolIBA 10/2019
1	Chalcone (Benzalacetophenone)IBA 10/2019
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 04/2018
1	Oncogene Proteins (Oncogene Protein)IBA 04/2018
1	LuteolinIBA 04/2018
1	Anti-Infective Agents (Microbicides)IBA 01/2018
1	UbiquitinIBA 10/2017
1	tanshinoneIBA 01/2016
1	Neuroprotective AgentsIBA 01/2015
1	fisetinIBA 01/2015
1	3-hydroxyflavoneIBA 01/2015
1	p38 Mitogen-Activated Protein KinasesIBA 01/2015
1	Amyloid (Amyloid Fibrils)IBA 01/2015
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2014
1	CurcuminIBA 11/2014
1	phorbolIBA 01/2013
1	Transcription Factors (Transcription Factor)IBA 01/2013
1	BerberineIBA 01/2012
1	5- hydroxy- 3,6,7,8,3',4'- hexamethoxyflavoneIBA 01/2011
1	Duloxetine Hydrochloride (Cymbalta)FDA Link 11/2010
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 11/2010
1	Antidepressive Agents (Antidepressants)IBA 11/2010
1	Dopamine Receptors (Dopamine Receptor)IBA 11/2010
1	Antipsychotic Agents (Antipsychotics)IBA 11/2010
1	Genetic Markers (Genetic Marker)IBA 12/2008

Therapy/Procedure

7	Therapeutics 01/2024 - 12/2016
1	Drug Therapy (Chemotherapy) 07/2022
1	Transjugular Intrahepatic Portasystemic Shunt 12/2021
1	Intranasal Administration 12/2021
1	Precision Medicine 11/2019
1	Aftercare (After-Treatment) 11/2010